Top Stories

Quantum BioPharma Buys Another $1 Million of Bitcoin and Other Crypto

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM), a biopharmaceutical company dedicated to building a portfolio of innovative…

Read More »

Why This Low Float Biotech Stock Looks Ripe for Another Big Breakout

Shares of Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM), an up-and-coming biotech stock with a tiny float,…

Read More »

Inflation Rises at Fastest Pace in 1.5 Years: What it Means for 2025 Fed Rate Cuts

Inflation is heating up again, casting doubt on hopes for Federal Reserve rate cuts in 2025. Fresh data from the…

Read More »

U Power Limited (UCAR): Why This Electric Vehicle Market Player’s Proprietary Battery-Swapping Technology is a Game-Changer

U Power Limited (NASDAQ: UCAR), along with its subsidiaries, is a leading electric vehicle (EV) market player primarily focused on…

Read More »

Quantum BioPharma Licensee Celly Nutrition Eyes IPO Following Highly Successful unbuzzd Clinical Trial

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced that its licensee, Celly Nutrition, the company behind unbuzzd™, the…

Read More »

The Winners and Losers From This Week’s Earnings

This week’s earnings reports painted a mixed picture across industries, with some companies outperforming expectations while others faltered amid shifting…

Read More »

U Power Accelerates Thailand’s EV Revolution with New Battery-Swapping Partnerships

U Power Limited (NASDAQ: UCAR), a China-based vehicle sourcing services provider, is expanding its footprint in Thailand through two high-profile…

Read More »

Quantum BioPharma Reports Successful Clinical Trial Results for Alcohol Detox Drink unbuzzd, QNTM Stock Soars 111% on 600X Volume

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced today the completion of its double-blind, randomized, placebo-controlled crossover…

Read More »

Why the Fed Left Rates Unchanged Despite Pressure from Trump

The Federal Reserve has decided to hold interest rates steady in its January 2025 policy meeting, resisting calls from President…

Read More »

Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe

Radiation therapy is a cornerstone of cancer treatment, with approximately 50% of cancer patients undergoing it during their illness. A…

Read More »
Back to top button
🔔
Stay Updated!
Get notifications for new content